HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pei-Jer Chen Selected Research

Hepatitis

1/2022Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis.
1/2022Acute-phase serum amyloid A for early detection of hepatocellular carcinoma in cirrhotic patients with low AFP level.
6/2021Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters.
1/2021Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan.
1/2021Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load.
1/2020Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection.
4/2016Chronic Hepatitis B Virus Infection: Disease Revisit and Management Recommendations.
2/2015Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers.
8/2014Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: clinical and mechanistic implications.
6/2014Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pei-Jer Chen Research Topics

Disease

116Infections
12/2022 - 01/2002
86Hepatocellular Carcinoma (Hepatoma)
08/2022 - 07/2002
66Hepatitis B
05/2022 - 01/2002
61Chronic Hepatitis B
03/2022 - 01/2002
54Neoplasms (Cancer)
08/2022 - 10/2002
43Fibrosis (Cirrhosis)
03/2022 - 09/2002
35Chronic Hepatitis C
01/2022 - 10/2002
30Hepatitis
01/2022 - 10/2002
20Liver Diseases (Liver Disease)
01/2022 - 09/2002
15Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 10/2002
15Hepatitis C
06/2020 - 11/2002
14Virus Diseases (Viral Diseases)
06/2021 - 01/2007
11Chronic Hepatitis (Chronic Active Hepatitis)
01/2022 - 09/2002
10Carcinogenesis
01/2022 - 04/2002
10Lymphoma (Lymphomas)
01/2021 - 06/2003
8Liver Neoplasms (Liver Cancer)
08/2022 - 11/2011
7Viremia
12/2020 - 12/2003
6Coinfection
05/2022 - 01/2002
4Human Influenza (Influenza)
06/2021 - 04/2008
4Hemorrhage
07/2020 - 05/2009
4Fatty Liver
06/2018 - 01/2005
4Hearing Loss (Hearing Impairment)
06/2015 - 06/2007
4Insulin Resistance
05/2010 - 08/2005
4Severe Acute Respiratory Syndrome
02/2009 - 05/2005
3Disease Progression
01/2021 - 02/2013
3HIV Infections (HIV Infection)
07/2020 - 12/2003
3Inflammation (Inflammations)
12/2019 - 12/2003
3Fatigue
02/2019 - 07/2010
3Hyperbilirubinemia
03/2018 - 04/2007
3Thrombocytopenia (Thrombopenia)
03/2016 - 08/2012
3Obesity
06/2015 - 07/2008

Drug/Important Bio-Agent (IBA)

54Antiviral Agents (Antivirals)IBA
12/2022 - 03/2004
51DNA (Deoxyribonucleic Acid)IBA
05/2022 - 01/2002
49Hepatitis B e AntigensIBA
01/2022 - 01/2002
43Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 07/2002
34InterferonsIBA
01/2022 - 11/2002
30Ribavirin (Virazole)FDA LinkGeneric
12/2020 - 11/2002
23Alanine Transaminase (SGPT)IBA
10/2020 - 01/2003
18Proteins (Proteins, Gene)FDA Link
10/2020 - 07/2004
16Sorafenib (BAY 43-9006)FDA Link
11/2017 - 01/2010
15Biomarkers (Surrogate Marker)IBA
05/2022 - 11/2011
14AntigensIBA
01/2022 - 01/2002
13RNA (Ribonucleic Acid)IBA
01/2022 - 06/2003
11VaccinesIBA
06/2021 - 05/2004
10Lamivudine (Epivir)FDA Link
02/2012 - 02/2004
9peginterferon alfa-2a (Pegasys)FDA Link
12/2020 - 02/2009
9Surface Antigens (Surface Antigen)IBA
01/2020 - 10/2003
8alpha-Fetoproteins (alpha-Fetoprotein)IBA
03/2022 - 06/2003
7AdiponectinIBA
06/2015 - 08/2005
7Interferon-alpha (Interferon Alfa)IBA
11/2008 - 12/2002
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2022 - 03/2004
6CytokinesIBA
05/2022 - 12/2003
6SofosbuvirIBA
09/2019 - 01/2017
6Phosphotransferases (Kinase)IBA
01/2017 - 07/2010
5AntibodiesIBA
01/2018 - 07/2002
5Codon (Codons)IBA
04/2013 - 01/2002
4Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 09/2004
4Gonadal Steroid Hormones (Sex Hormones)IBA
05/2021 - 07/2010
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2020 - 07/2010
4Rituximab (Mabthera)FDA Link
01/2020 - 06/2014
4daclatasvirIBA
02/2019 - 01/2017
4Pharmaceutical PreparationsIBA
01/2019 - 01/2006
4Triglycerides (Triacylglycerol)IBA
06/2018 - 06/2008
4Androgen Receptors (Androgen Receptor)IBA
10/2015 - 07/2002
4Estrogens (Estrogen)FDA Link
02/2015 - 02/2009
4MicroRNAs (MicroRNA)IBA
01/2013 - 02/2009
4Amino AcidsFDA Link
01/2011 - 09/2002
3acarboxyprothrombin (PIVKA)IBA
08/2022 - 06/2013
3ChemokinesIBA
05/2022 - 01/2014
3Nucleic AcidsIBA
01/2022 - 01/2006
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 09/2004
3Peptides (Polypeptides)IBA
06/2021 - 09/2004
3NucleotidesIBA
06/2021 - 10/2002
3sofosbuvir drug combination ledipasvirIBA
10/2020 - 01/2017
3Circular DNAIBA
06/2020 - 08/2014
3Immunoglobulin G (IgG)IBA
01/2020 - 06/2004
3CholesterolIBA
01/2018 - 06/2008
3ledipasvirIBA
01/2018 - 01/2018
3STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2017 - 11/2011
3Therapeutic UsesIBA
04/2016 - 05/2003
3Membrane Proteins (Integral Membrane Proteins)IBA
04/2016 - 09/2002
3eltrombopagFDA Link
03/2016 - 08/2012
3Interleukin-6 (Interleukin 6)IBA
06/2015 - 12/2009
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2014 - 04/2011
3tigatuzumabIBA
02/2013 - 05/2011
3AndrogensIBA
08/2012 - 04/2007
3LigandsIBA
03/2012 - 04/2009
3Bortezomib (Velcade)FDA Link
05/2011 - 04/2009

Therapy/Procedure

100Therapeutics
05/2022 - 11/2002
13Drug Therapy (Chemotherapy)
01/2021 - 06/2003
5Aftercare (After-Treatment)
01/2022 - 07/2005
5Duration of Therapy
06/2020 - 05/2005
5Highly Active Antiretroviral Therapy (HAART)
02/2012 - 12/2003
4Immunotherapy
01/2019 - 05/2003
4Ligation
11/2017 - 01/2012
3Liver Transplantation
01/2022 - 06/2013
3Blood Transfusion (Blood Transfusions)
01/2022 - 12/2002
3Injections
12/2020 - 05/2003
3Radiotherapy
01/2018 - 02/2007
3Renal Dialysis (Hemodialysis)
05/2011 - 07/2010